HOME >> BIOLOGY >> NEWS
Colon Cancer Alliance launches interactive support program

CHICAGO September 14, 2006 -- Every four minutes someone in the United States is diagnosed with colorectal cancer, a diagnosis that can be overwhelming without appropriate information and support. People living with colorectal cancer now have the opportunity to exchange ideas and information with experts in the field and fellow patients through an educational workshop series called "Conversations About Colorectal Cancer." The program launches this weekend at the Colon Cancer Alliance's (CCA) 6th Annual Colorectal Cancer Conference in Chicago.

The two-day interactive conference will allow patients to have a dialogue with thought-leading physicians in the area of colorectal cancer on a range of topics, from the latest treatment advances with targeted therapies to managing their side effects. In addition, patients and caregivers will have the opportunity to listen to, and support one another, in their collective battle against colorectal cancer.

"This program is an important way for those living with colorectal cancer to learn more about the nation's second-leading cancer killer," says Amy Kelly, Co-Founder and Executive Director of the Colon Cancer Alliance. "By encouraging increased dialogue between patients, health care providers and caregivers, we hope to help patients learn how to successfully continue their daily activities and ultimately improve their quality of life."

According to a Harris Interactive survey of more than 500 cancer patients and 300 oncologists, patients who held discussions with their physicians about cancer topics were more knowledgeable about their condition than those who did not hold discussions. For example, only 10 percent of patients who did not participate in dialogue with their physician were knowledgeable about the extent of available treatment options. In addition, patients who did not have discussions with their physician were less knowledgeable about the possibility of treatment delays, infe
'"/>

Contact: Amy E. Kelly
akelly@ccalliance.org
954-341-0212
Porter Novelli
14-Sep-2006


Page: 1 2

Related biology news :

1. Smithsonian Fragmentation Project threatened by Amazon Colonization Plan
2. Kidnapped: Colon cancer seizes hapless nerve growth protein
3. Journalists can register now for ECCO 14 -- the European Cancer Conference
4. Cancer cures could work for canines and humans
5. The Cancer Genome Atlas awards funds for technology development
6. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
7. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
8. Cancer stem cells can go it alone
9. Cancer drug enhances long-term memory
10. Cancer cells reprogram energy needs to grow and spread, study suggests
11. Cancer scientists create human leukemia process to map how disease begins, progresses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/9/2016)... Nigeria . Recently, ... 23,000 public service employees either did not exist with ... unlawfully.    --> Nigeria . ... than 23,000 public service employees either did not exist ... salary unlawfully.    --> DERMALOG, the biometrics ...
(Date:3/3/2016)... 3, 2016  FlexTech, a SEMI Strategic Association Partner, ... Research & Development, Leadership in Education, and, in a ... 9 th year of the FLEXI Awards and ... individuals from past years . Judging was done ... set of criteria, by a panel of non-affiliated, independent, ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... ... May 05, 2016 , ... CereScan, ... the National Stroke Association during National Stroke Awareness Month in May. An ... pages throughout the month. CereScan will donate $1 up to a maximum ...
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... ... May 04, 2016 , ... PBI-Gordon Corporation is pleased to announce ... , Doug began his career at PBI-Gordon in February 1988, after finishing his masters ... of roles, ranging from customer service to national product manager, to helping develop, name ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... enterprise talent development, skill-building and compliance training platform on mobile devices, today ... course: Overview of Regulatory Requirements for Medical Devices. The course is essential for ...
Breaking Biology Technology:
Cached News: